Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Journal of Hepatology
|
July 25, 2000
Differential leptin responses to acute and chronic biliary obstruction in rats
K P Rioux, P L Beck, A G Hoppin, et al.
British Journal of Pharmacology
|
May 15, 2003
Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats
K S Park, Y Li, Y Zhang, et al.
Hepatology (Baltimore, Md.)
|
March 21, 1998
Open-label trial of oral nalmefene therapy for the pruritus of cholestasis
N V Bergasa, J M Schmitt, T L Talbot, et al.
Journal of Hepatology
|
August 1, 1994
Therapy of chronic hepatitis B with a 6-month course of ribavirin
M W Fried, T L Fong, M G Swain, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
February 15, 2007
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial
A Chatterjee, M G Swain, S S Lee, et al.
Annals of Internal Medicine
|
August 1, 1995
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial
N V Bergasa, D W Alling, T L Talbot, et al.
Alimentary Pharmacology & Therapeutics
|
July 15, 2017
Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers
A A Shaheen, M AlMattooq, S Yazdanfar, et al.
The American Journal of Gastroenterology
|
November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B
A M Di Bisceglie, T L Fong, M W Fried, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis C
A M Di Bisceglie, M Shindo, T L Fong, et al.
Alimentary Pharmacology & Therapeutics
|
September 14, 2017
Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply
A A Shaheen, M Al-Mattooq, S Yazdanfar, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Journal of Hepatology
|
July 25, 2000
Differential leptin responses to acute and chronic biliary obstruction in rats
K P Rioux, P L Beck, A G Hoppin, et al.
British Journal of Pharmacology
|
May 15, 2003
Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats
K S Park, Y Li, Y Zhang, et al.
Hepatology (Baltimore, Md.)
|
March 21, 1998
Open-label trial of oral nalmefene therapy for the pruritus of cholestasis
N V Bergasa, J M Schmitt, T L Talbot, et al.
Journal of Hepatology
|
August 1, 1994
Therapy of chronic hepatitis B with a 6-month course of ribavirin
M W Fried, T L Fong, M G Swain, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
February 15, 2007
Induction versus noninduction antiviral therapy for chronic hepatitis C virus in patients with congenital coagulation disorders: a Canadian multicentre trial
A Chatterjee, M G Swain, S S Lee, et al.
Annals of Internal Medicine
|
August 1, 1995
Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial
N V Bergasa, D W Alling, T L Talbot, et al.
Alimentary Pharmacology & Therapeutics
|
July 15, 2017
Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers
A A Shaheen, M AlMattooq, S Yazdanfar, et al.
The American Journal of Gastroenterology
|
November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B
A M Di Bisceglie, T L Fong, M W Fried, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1992
A pilot study of ribavirin therapy for chronic hepatitis C
A M Di Bisceglie, M Shindo, T L Fong, et al.
Alimentary Pharmacology & Therapeutics
|
September 14, 2017
Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply
A A Shaheen, M Al-Mattooq, S Yazdanfar, et al.
Page
of 6